Brain Structural Abnormalities in Patients With Vertigo
1 other identifier
observational
464
1 country
1
Brief Summary
Introduction: Dizziness is one of the most common complaints in medical practice and is associated with various underlying conditions, including neurological, otolaryngological, and psychological disorders. Preliminary imaging studies like CT, cervical spine X-rays, and carotid/vertebral artery ultrasound, aids in precise diagnosis and targeted therapeutic decisions. MRI is one of the most effective imaging modalities currently available for examining the brain. Purpose: To identify structural brain changes linked to vertigo, explore pre-MRI diagnostic approaches, and evaluate treatment strategies. Methods: The study included 232 patients with vertigo and 232 control subjects. MRI results were categorized, and pre-MRI examinations, symptoms, and treatments were analyzed. Statistical comparisons were conducted using chi-square and t-tests, with significance set at p\<0.05.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedFirst Submitted
Initial submission to the registry
February 11, 2025
CompletedFirst Posted
Study publicly available on registry
February 27, 2025
CompletedFebruary 27, 2025
February 1, 2025
2.3 years
February 11, 2025
February 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Occurrences With Specific Structural Brain Abnormalities Observed on MRI
Brain MRI findings were analyzed to compare the occurrences of structural abnormalities between vertigo patients and control participants. The most commonly assessed abnormalities included white matter lesions, lacunar infarcts, Circle of Willis variations, and sinusitis. The occurrences (number and percentage) of these findings in each group will be compared using chi-square tests.
From September 2020 to December 2022
Secondary Outcomes (4)
Occurrences of associated symptoms in vertigo patients
From September 2020 to December 2022
Occurrences of pre-MRI diagnostic procedures in vertigo patients
From September 2020 to December 2022
Occurrences of post-MRI diagnoses in vertigo patients
From September 2020 to December 2022
Occurrences of treatment strategies applied
From September 2020 to December 2022
Study Arms (2)
Vertigo Group
Participants in this group reported dizziness as a primary symptom and were referred for brain MRI to investigate potential structural abnormalities. Exclusion criteria included any pre-existing neurological disorders. The most common diagnoses after MRI included benign paroxysmal positional vertigo (BPPV) and vertebrobasilar syndrome.
Control Group
Participants in this group did not report dizziness or other neurological symptoms. They underwent brain MRI for other reasons but had no history of neurological disorders. This group served as a comparison to evaluate the prevalence of brain structural abnormalities in vertigo patients.
Interventions
This is an observational study evaluating brain structural abnormalities in post-COVID headache patients. No experimental intervention is applied.
Eligibility Criteria
The study population consisted of adult patients (≥18 years) with vertigo who were referred for brain MRI to investigate potential structural abnormalities. A control group of individuals without a history of vertigo or neurological disorders was included for comparison. Exclusion criteria included prior neurological diseases, recent head trauma, and MRI contraindications.
You may qualify if:
- Age ≥18 years
- Reported dizziness (vertigo) as a primary symptom
- Brain MRI requested by the attending physician
You may not qualify if:
- Prior neurological disease or disorder (other than vertigo/dizziness in the vertigo group)
- MRI contraindications (e.g., pacemaker, metal implants, claustrophobia)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Szent Margit Hospital
Budapest, 1032, Hungary
Related Publications (1)
Szephelyi K, Kora S, Orsi G, Tollar J. Structural Brain Abnormalities, Diagnostic Approaches, and Treatment Strategies in Vertigo: A Case-Control Study. Neurol Int. 2025 Sep 10;17(9):146. doi: 10.3390/neurolint17090146.
PMID: 41002934DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Klaudia Széphelyi
University of Pécs, Faculty of Health Sciences, Hungary
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 11, 2025
First Posted
February 27, 2025
Study Start
September 1, 2020
Primary Completion
December 31, 2022
Study Completion
December 31, 2022
Last Updated
February 27, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share